Sen A, Das C, Mukhopadhyay M, Mukhopadhyay S, Deb S, Mukhopadhyay B
Department of Pathology, The Institute of Post-Graduate Medical Education and Research, Kolkata, West Bengal, India.
Department of Endocrinology, The Institute of Post-Graduate Medical Education and Research, Kolkata, West Bengal, India.
J Postgrad Med. 2017 Apr-Jun;63(2):96-99. doi: 10.4103/0022-3859.192797.
Tumors of the pituitary gland and sellar region represent approximately 10-15% of all brain tumors. Pituitary adenoma (PA), the most common pathology of the pituitary gland, can be effectively subclassified only with the help of immunohistochemistry (IHC). This is important and needed for individual patient management.
The objective of the study was to analyze the importance of intraoperative imprint smear cytology and correlating with final histopathological diagnosis. Furthermore, to classify the different types of PA with the help of IHC, prolactin (PRL), adrenocorticotropic hormone (ACTH), and growth hormone (GH) and to predict the benign, atypical, or malignant nature of the tumor with the help of prognostic marker Ki-67.
A prospective study was done in 34 cases. The patients whose pituitary gland samples are referred from the endocrine and the neurosurgery department to the pathology department for histopathological examinations were selected. We have studied the clinical features, radiology and touch imprint cytology, histopathology, and IHC with the help of PRL, ACTH, GH, and Ki-67 of PA over 2 years.
In our study, we had 32 cases of PA of 34 cases over a span of 2 years. We have seen that there is a correlation between cytological and histological diagnosis of the subtypes of PA in 62% cases, and the Kappa statistics show a moderate extent of agreement (Kappa - 0.320, 95% confidence interval = 0.031-0.609). Ki-67 when compared to the radiological grading showed a high degree of comparability (Chi-square test: P < 0.001). All cases with invasion had a higher Ki-67. On using the Fisher's exact test, we found that the Ki-67 expression with GH-producing adenomas and ACTH-producing adenomas was comparable (P = 1.000) while in PRL-producing adenomas too this was not significant (P = 0.269).
PA can be effectively classified with the help of IHC. Intraoperative cytology is important in diagnosing PA, but histopathology remains the gold standard in diagnosing and differentiating PA from other pathologies of the pituitary gland. The radiological grading together with immunological classification and the prognostic markers of Ki-67 is important in deciding the benign or atypical nature of the adenomas thus helping in better patient management.
垂体和鞍区肿瘤约占所有脑肿瘤的10 - 15%。垂体腺瘤(PA)是垂体最常见的病理类型,只有借助免疫组织化学(IHC)才能有效地进行亚分类。这对于个体患者的管理很重要且必要。
本研究的目的是分析术中印片涂片细胞学检查的重要性,并与最终的组织病理学诊断相关联。此外,借助免疫组织化学对不同类型的垂体腺瘤进行分类,检测催乳素(PRL)、促肾上腺皮质激素(ACTH)和生长激素(GH),并借助预后标志物Ki-67预测肿瘤的良性、非典型或恶性性质。
对34例患者进行了一项前瞻性研究。选择了那些垂体样本从内分泌科和神经外科转至病理科进行组织病理学检查的患者。我们在两年时间里研究了垂体腺瘤的临床特征、放射学表现、触诊印片细胞学、组织病理学以及借助PRL、ACTH、GH和Ki-67进行的免疫组织化学检查。
在我们的研究中,在两年时间里的34例患者中有32例垂体腺瘤。我们发现,62%的病例中垂体腺瘤亚型的细胞学诊断与组织学诊断之间存在相关性,Kappa统计显示一致性程度中等(Kappa = 0.320,95%置信区间 = 0.031 - 0.609)。与放射学分级相比,Ki-67显示出高度的可比性(卡方检验:P < 0.001)。所有侵袭性病例的Ki-67水平较高。使用Fisher精确检验时,我们发现生长激素分泌型腺瘤和促肾上腺皮质激素分泌型腺瘤的Ki-67表达具有可比性(P = 1.000),而在催乳素分泌型腺瘤中这也不显著(P = 0.269)。
借助免疫组织化学可以有效地对垂体腺瘤进行分类。术中细胞学检查在垂体腺瘤的诊断中很重要,但组织病理学仍然是诊断垂体腺瘤并将其与垂体其他病理类型区分开来的金标准。放射学分级连同免疫分类以及Ki-67的预后标志物在确定腺瘤的良性或非典型性质方面很重要,从而有助于更好地管理患者。